Hanfstein, B., Shlyakhto, V., Lauseker, M., Hehlmann, R., Saussele, S., Dietz, C., . . . Stegelmann, F. (2014). Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib. Leukemia (08876924), 28(10), 1988-1993.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Hanfstein, B., et al. "Velocity of Early BCR-ABL Transcript Elimination as an Optimized Predictor of Outcome in Chronic Myeloid Leukemia (CML) Patients in Chronic Phase on Treatment with Imatinib."
Leukemia (08876924) 28, no. 10 (2014): 1988-1993.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Hanfstein, B., et al. "Velocity of Early BCR-ABL Transcript Elimination as an Optimized Predictor of Outcome in Chronic Myeloid Leukemia (CML) Patients in Chronic Phase on Treatment with Imatinib."
Leukemia (08876924), vol. 28, no. 10, 2014, pp. 1988-1993.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.